Which is better, SANOFICONR.BO or SANOFICONR.NS?

SANOFICONR.BO and SANOFICONR.NS tie on the headline Buffett-Fit score (78/100 each). The decision comes down to which underlying framework you trust most — SANOFICONR.BO leads on none; SANOFICONR.NS leads on none. The pillar-by-pillar breakdown is on this page.

Should I buy SANOFICONR.BO or SANOFICONR.NS?

This page is an educational comparison, not investment advice. Both SANOFICONR.BO and SANOFICONR.NS are graded against the same Buffett 5-pillar framework (moat, earnings durability, management quality, financial health, valuation) plus six other documented investor frameworks. Read the side-by-side breakdown to see which one matches the criteria you care about most — and always do your own research before making any investment decision.

Is SANOFICONR.BO better than SANOFICONR.NS for value investing?

The two are close on the headline Buffett-Fit score (78/100 vs 78/100), so "better for value investing" depends on which pillar you weight most. The five Buffett pillars + six other frameworks are broken down side-by-side on this page so you can pick the one that fits your style.

What's the difference between SANOFICONR.BO and SANOFICONR.NS on Warren Buffett's framework?

Both stocks are evaluated on the same five pillars: economic moat (durable competitive advantage), earnings durability (consistent profitability), management quality (capital allocation), financial health (conservative balance sheet), and valuation (margin of safety). SANOFICONR.BO currently scores 78/100 (B grade); SANOFICONR.NS scores 78/100 (B grade). The "Where each wins" section on this page breaks down which pillar each stock dominates.

Which has the stronger moat, SANOFICONR.BO or SANOFICONR.NS?

Moat strength is one of the five pillars in the Buffett-Fit score on this page. SANOFICONR.BO and SANOFICONR.NS are each scored on ROIC sustainability, gross-margin durability, and qualitative signals like brand strength, switching costs, network effects, and regulatory barriers. The pillar breakdown on this page shows the moat sub-score side-by-side so you can see which one has the more durable competitive advantage.

Which is more undervalued, SANOFICONR.BO or SANOFICONR.NS?

Valuation is one of the five Buffett-Fit pillars on this page. Both stocks are scored on owner-earnings yield, price-to-intrinsic-value vs the underlying compounding rate, and the margin of safety relative to a conservative DCF. The valuation sub-score in the table below tells you which one currently trades at a more attractive price relative to its underlying business quality.

Are SANOFICONR.BO and SANOFICONR.NS both Healthcare stocks?

Yes — both Sanofi Consumer Healthcare India Limited (SANOFICONR.BO) and SANOFI CONS HEALTHC IND L (SANOFICONR.NS) operate in the Healthcare sector. That makes this a direct sector-peer comparison, which is the apples-to-apples way to use the Buffett-Fit framework: the score weighs each stock against its sector's specific quality and valuation benchmarks (sector-relative bonus), so the cross-stock comparison isn't distorted by inter-sector base-rate differences.

Is this SANOFICONR.BO vs SANOFICONR.NS comparison investment advice?

No. This page is an educational pattern-match against documented public frameworks (Buffett, Graham, Fisher, Lynch, Greenblatt, Munger, Smith), not personalised investment advice. The scores reflect how closely each stock matches each framework's documented criteria — they are not buy/hold/sell recommendations. Always do your own research and consult a licensed financial adviser for personalised advice.

Stock comparison

Sanofi Consumer Healthcare India Limited

SANOFICONR.BO$104.46BHealthcare Market cap, Sector

SANOFI CONS HEALTHC IND L

SANOFICONR.NS$104.97BHealthcare Market cap, Sector

Overall winner

Tie

SANOFICONR.BO 00 SANOFICONR.NS

Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.

Fit scores by strategy

SANOFICONR.BO0wins

0winsSANOFICONR.NS

Warren Buffett

78B

B78

Benjamin Graham

89A

A89

Philip Fisher

83B

B83

Peter Lynch

77B

B77

Joel Greenblatt

91A

A91

Charlie Munger

86A

A86

Terry Smith

85A

A85

Side-by-side metrics

Metric	SANOFICONR.BO	SANOFICONR.NS
Market cap	$104.46B	$104.97B Winner
P/E (TTM)	Winner: 44.0x	44.2x
EV/EBIT	Winner: 31.7x	31.8x
ROIC (TTM)	59.15%	59.15%
Gross margin	68.13%	68.13%
Net margin	27.35%	27.35%
Revenue CAGR 5y	27.01%	27.01%
EPS CAGR 5y	20.67%	20.67%
Debt / Equity	0.1x	0.1x
Dividend yield	-	-

More like SANOFICONR.BO

SANOFICONR.BO vs JSLL.NS SANOFICONR.BO vs JSLL.BO SANOFICONR.BO vs 4728.TWO SANOFICONR.BO vs PME.AX

More like SANOFICONR.NS

SANOFICONR.NS vs JSLL.NS SANOFICONR.NS vs JSLL.BO SANOFICONR.NS vs 4728.TWO SANOFICONR.NS vs PME.AX

Read the full Buffett-Brain analysis for SANOFICONR.BO Read the full Buffett-Brain analysis for SANOFICONR.NS

Related on invest-like

Strongest Moat Highest ROIC Warren Buffett strategy Economic Moat

Key terms in this analysis

ROIC Free Cash Flow (FCF)Economic Moat P/E Ratio Margin of Safety Quality Score

Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.